Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.20968562 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.20968562 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.17129670 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.17129670 |
5 | serine family amino acid catabolic process (GO:0009071) | 6.13944192 |
6 | lysine catabolic process (GO:0006554) | 5.98735035 |
7 | lysine metabolic process (GO:0006553) | 5.98735035 |
8 | glyoxylate metabolic process (GO:0046487) | 5.97599117 |
9 | cysteine metabolic process (GO:0006534) | 5.92555916 |
10 | aromatic amino acid family catabolic process (GO:0009074) | 5.81277497 |
11 | glycine metabolic process (GO:0006544) | 5.59241206 |
12 | urate metabolic process (GO:0046415) | 5.45345187 |
13 | serine family amino acid metabolic process (GO:0009069) | 5.43588319 |
14 | indole-containing compound catabolic process (GO:0042436) | 5.43336283 |
15 | indolalkylamine catabolic process (GO:0046218) | 5.43336283 |
16 | tryptophan catabolic process (GO:0006569) | 5.43336283 |
17 | kynurenine metabolic process (GO:0070189) | 5.36611270 |
18 | serine family amino acid biosynthetic process (GO:0009070) | 5.33739580 |
19 | amino-acid betaine metabolic process (GO:0006577) | 5.21861174 |
20 | homocysteine metabolic process (GO:0050667) | 5.18448148 |
21 | tryptophan metabolic process (GO:0006568) | 5.12237527 |
22 | drug catabolic process (GO:0042737) | 4.82568008 |
23 | sulfur amino acid catabolic process (GO:0000098) | 4.76827580 |
24 | folic acid metabolic process (GO:0046655) | 4.72954331 |
25 | drug transmembrane transport (GO:0006855) | 4.61962434 |
26 | bile acid biosynthetic process (GO:0006699) | 4.61824340 |
27 | alpha-amino acid catabolic process (GO:1901606) | 4.61547644 |
28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.59035269 |
29 | aromatic amino acid family metabolic process (GO:0009072) | 4.58577799 |
30 | fructose metabolic process (GO:0006000) | 4.56596594 |
31 | urea cycle (GO:0000050) | 4.56554996 |
32 | urea metabolic process (GO:0019627) | 4.56554996 |
33 | aspartate family amino acid catabolic process (GO:0009068) | 4.42072596 |
34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.41426177 |
35 | alpha-linolenic acid metabolic process (GO:0036109) | 4.41338858 |
36 | cellular amino acid catabolic process (GO:0009063) | 4.37088956 |
37 | exogenous drug catabolic process (GO:0042738) | 4.36795453 |
38 | glutamate metabolic process (GO:0006536) | 4.30354286 |
39 | establishment of integrated proviral latency (GO:0075713) | 4.28035960 |
40 | cellular modified amino acid catabolic process (GO:0042219) | 4.22285005 |
41 | cellular ketone body metabolic process (GO:0046950) | 4.21734622 |
42 | 2-oxoglutarate metabolic process (GO:0006103) | 4.21183854 |
43 | nitrogen cycle metabolic process (GO:0071941) | 4.19393127 |
44 | drug transport (GO:0015893) | 4.17872082 |
45 | IMP biosynthetic process (GO:0006188) | 4.13324079 |
46 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.08526528 |
47 | L-serine metabolic process (GO:0006563) | 4.05455168 |
48 | negative regulation of fibrinolysis (GO:0051918) | 3.99592433 |
49 | carnitine metabolic process (GO:0009437) | 3.98726077 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 3.96193462 |
51 | bile acid metabolic process (GO:0008206) | 3.94962412 |
52 | negative regulation of cholesterol transport (GO:0032375) | 3.92188687 |
53 | negative regulation of sterol transport (GO:0032372) | 3.92188687 |
54 | phosphate ion transmembrane transport (GO:0035435) | 3.89575730 |
55 | phosphate ion transport (GO:0006817) | 3.84449641 |
56 | chromatin remodeling at centromere (GO:0031055) | 3.83147058 |
57 | acetyl-CoA metabolic process (GO:0006084) | 3.82081088 |
58 | mitotic metaphase plate congression (GO:0007080) | 3.81727041 |
59 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.79245632 |
60 | protein carboxylation (GO:0018214) | 3.79245632 |
61 | tyrosine metabolic process (GO:0006570) | 3.77201834 |
62 | regulation of protein activation cascade (GO:2000257) | 3.76731377 |
63 | high-density lipoprotein particle remodeling (GO:0034375) | 3.73282901 |
64 | organic acid catabolic process (GO:0016054) | 3.72516510 |
65 | carboxylic acid catabolic process (GO:0046395) | 3.72516510 |
66 | CENP-A containing nucleosome assembly (GO:0034080) | 3.72212431 |
67 | indolalkylamine metabolic process (GO:0006586) | 3.72052371 |
68 | ribosome assembly (GO:0042255) | 3.70867370 |
69 | ketone body metabolic process (GO:1902224) | 3.69138918 |
70 | IMP metabolic process (GO:0046040) | 3.67077024 |
71 | regulation of fibrinolysis (GO:0051917) | 3.64329436 |
72 | response to mercury ion (GO:0046689) | 3.61501945 |
73 | regulation of cholesterol homeostasis (GO:2000188) | 3.61112232 |
74 | amine catabolic process (GO:0009310) | 3.60085089 |
75 | cellular biogenic amine catabolic process (GO:0042402) | 3.60085089 |
76 | purine nucleobase biosynthetic process (GO:0009113) | 3.58696346 |
77 | cellular glucuronidation (GO:0052695) | 3.57904704 |
78 | sulfur amino acid metabolic process (GO:0000096) | 3.55719619 |
79 | branched-chain amino acid catabolic process (GO:0009083) | 3.55141348 |
80 | regulation of complement activation (GO:0030449) | 3.53128941 |
81 | benzene-containing compound metabolic process (GO:0042537) | 3.48993368 |
82 | heme transport (GO:0015886) | 3.48690553 |
83 | arginine metabolic process (GO:0006525) | 3.48555087 |
84 | protein localization to kinetochore (GO:0034501) | 3.48177552 |
85 | dicarboxylic acid metabolic process (GO:0043648) | 3.47062253 |
86 | tricarboxylic acid metabolic process (GO:0072350) | 3.45187382 |
87 | pantothenate metabolic process (GO:0015939) | 3.42417359 |
88 | ethanol oxidation (GO:0006069) | 3.42151009 |
89 | branched-chain amino acid metabolic process (GO:0009081) | 3.41932355 |
90 | DNA replication checkpoint (GO:0000076) | 3.41178472 |
91 | fatty acid beta-oxidation (GO:0006635) | 3.37941027 |
92 | histone exchange (GO:0043486) | 3.37413501 |
93 | folic acid transport (GO:0015884) | 3.37315078 |
94 | modified amino acid transport (GO:0072337) | 3.37253969 |
95 | one-carbon metabolic process (GO:0006730) | 3.37219916 |
96 | drug metabolic process (GO:0017144) | 3.36992200 |
97 | complement activation, alternative pathway (GO:0006957) | 3.36520149 |
98 | sulfur amino acid biosynthetic process (GO:0000097) | 3.35888175 |
99 | regulation of bile acid biosynthetic process (GO:0070857) | 3.34338030 |
100 | imidazole-containing compound metabolic process (GO:0052803) | 3.34163297 |
101 | triglyceride homeostasis (GO:0070328) | 3.32227638 |
102 | acylglycerol homeostasis (GO:0055090) | 3.32227638 |
103 | metaphase plate congression (GO:0051310) | 3.30577081 |
104 | folic acid-containing compound metabolic process (GO:0006760) | 3.30487953 |
105 | fatty acid oxidation (GO:0019395) | 3.29845104 |
106 | valine metabolic process (GO:0006573) | 3.26001434 |
107 | regulation of helicase activity (GO:0051095) | 3.25272987 |
108 | glutamine family amino acid catabolic process (GO:0009065) | 3.25220253 |
109 | aspartate family amino acid metabolic process (GO:0009066) | 3.25113567 |
110 | protein complex localization (GO:0031503) | 3.24069569 |
111 | lipid oxidation (GO:0034440) | 3.23899096 |
112 | nucleobase biosynthetic process (GO:0046112) | 3.23440068 |
113 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.22411274 |
114 | bile acid and bile salt transport (GO:0015721) | 3.22243429 |
115 | establishment of viral latency (GO:0019043) | 3.21944028 |
116 | coenzyme catabolic process (GO:0009109) | 3.21743412 |
117 | nuclear pore complex assembly (GO:0051292) | 3.15073740 |
118 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.14403685 |
119 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.14403685 |
120 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.14403685 |
121 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.14403685 |
122 | negative regulation of sister chromatid segregation (GO:0033046) | 3.14403685 |
123 | spindle checkpoint (GO:0031577) | 3.13374855 |
124 | mitotic spindle checkpoint (GO:0071174) | 3.10843031 |
125 | negative regulation of chromosome segregation (GO:0051985) | 3.10829884 |
126 | nuclear pore organization (GO:0006999) | 3.08906397 |
127 | DNA double-strand break processing (GO:0000729) | 3.08808098 |
128 | cholesterol biosynthetic process (GO:0006695) | 3.05050651 |
129 | DNA replication-independent nucleosome organization (GO:0034724) | 3.03329120 |
130 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.03329120 |
131 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.02463127 |
132 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.99341501 |
133 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.97482128 |
134 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.97482128 |
135 | cellular protein complex localization (GO:0034629) | 2.94615362 |
136 | proteasome assembly (GO:0043248) | 2.93907313 |
137 | anterior/posterior axis specification, embryo (GO:0008595) | 2.93200288 |
138 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.89407814 |
139 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.89407814 |
140 | DNA strand elongation (GO:0022616) | 2.87895021 |
141 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.87402636 |
142 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.87402636 |
143 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.86226063 |
144 | regulation of cofactor metabolic process (GO:0051193) | 2.84507691 |
145 | regulation of coenzyme metabolic process (GO:0051196) | 2.84507691 |
146 | DNA damage response, detection of DNA damage (GO:0042769) | 2.83366187 |
147 | mitotic sister chromatid segregation (GO:0000070) | 2.82707159 |
148 | ventricular cardiac muscle cell development (GO:0055015) | 2.82684765 |
149 | sterol biosynthetic process (GO:0016126) | 2.81815262 |
150 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.81501821 |
151 | DNA strand renaturation (GO:0000733) | 2.79965502 |
152 | regulation of chromosome segregation (GO:0051983) | 2.77659158 |
153 | mitotic spindle assembly checkpoint (GO:0007094) | 2.77536828 |
154 | non-recombinational repair (GO:0000726) | 2.76136249 |
155 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.76136249 |
156 | negative regulation of DNA recombination (GO:0045910) | 2.74725276 |
157 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.73842057 |
158 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.72929125 |
159 | tricarboxylic acid cycle (GO:0006099) | 2.71974451 |
160 | regulation of centriole replication (GO:0046599) | 2.71429305 |
161 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.70894530 |
162 | spindle assembly checkpoint (GO:0071173) | 2.70504766 |
163 | protein localization to chromosome, centromeric region (GO:0071459) | 2.69862056 |
164 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.69125135 |
165 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.68413182 |
166 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.68413182 |
167 | regulation of sister chromatid segregation (GO:0033045) | 2.68413182 |
168 | DNA ligation (GO:0006266) | 2.67849369 |
169 | female gonad development (GO:0008585) | 2.66344359 |
170 | RNA-dependent DNA replication (GO:0006278) | 2.66205203 |
171 | glutamine metabolic process (GO:0006541) | 2.65715902 |
172 | tRNA aminoacylation for protein translation (GO:0006418) | 2.65577451 |
173 | telomere maintenance via telomerase (GO:0007004) | 2.64975779 |
174 | aldehyde catabolic process (GO:0046185) | 2.64430961 |
175 | plasma lipoprotein particle assembly (GO:0034377) | 2.64120311 |
176 | negative regulation of mitosis (GO:0045839) | 2.61904577 |
177 | sister chromatid segregation (GO:0000819) | 2.61885985 |
178 | cullin deneddylation (GO:0010388) | 2.61834176 |
179 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.61294200 |
180 | mitotic nuclear envelope disassembly (GO:0007077) | 2.58481695 |
181 | tRNA aminoacylation (GO:0043039) | 2.58360932 |
182 | amino acid activation (GO:0043038) | 2.58360932 |
183 | mitotic sister chromatid cohesion (GO:0007064) | 2.58294091 |
184 | pre-miRNA processing (GO:0031054) | 2.54883781 |
185 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.53139116 |
186 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.53139116 |
187 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.51895816 |
188 | lactate metabolic process (GO:0006089) | 2.51521223 |
189 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.50483145 |
190 | negative regulation of ligase activity (GO:0051352) | 2.50328444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.21847248 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.74102331 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10567924 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.14158264 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.06259134 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.77359484 |
7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.34975665 |
8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.19478308 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.16173887 |
10 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.84558591 |
11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.82292944 |
12 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.53201152 |
13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.43987645 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.42747958 |
15 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.41629943 |
16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.23711250 |
17 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.22673229 |
18 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.14914330 |
19 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.05381709 |
20 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.99627791 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98720251 |
22 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.97088824 |
23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96872701 |
24 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.89871011 |
25 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.86699378 |
26 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.85605568 |
27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.83471151 |
28 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.80405424 |
29 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79832993 |
30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.76122463 |
31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73943803 |
32 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.73405839 |
33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.73357395 |
34 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.69430120 |
35 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.69297610 |
36 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.69141924 |
37 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.68886176 |
38 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.63731641 |
39 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62336607 |
40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.60655829 |
41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.56838501 |
42 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.55311720 |
43 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.54033256 |
44 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51862579 |
45 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.51424545 |
46 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51257720 |
47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.49115130 |
48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.47967379 |
49 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.45484266 |
50 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44688646 |
51 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.44232870 |
52 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43294602 |
53 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.39969695 |
54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.39714958 |
55 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37092364 |
56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.36492688 |
57 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.31212642 |
58 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.30573071 |
59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.29963100 |
60 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.29942617 |
61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29053302 |
62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.26631365 |
63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.22303503 |
64 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.21489906 |
65 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.21307210 |
66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20587046 |
67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.20124876 |
68 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.18310070 |
69 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.17425710 |
70 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.16044331 |
71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14906515 |
72 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.14874569 |
73 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13779992 |
74 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.13173937 |
75 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.12632019 |
76 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.12310506 |
77 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.11635100 |
78 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11076193 |
79 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.10689362 |
80 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.09437633 |
81 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07788837 |
82 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.07081818 |
83 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.06964796 |
84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.06183948 |
85 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.06111078 |
86 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.05807930 |
87 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.05729680 |
88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.05601860 |
89 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03489833 |
90 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.02444054 |
91 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.01857277 |
92 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.01246062 |
93 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.00789623 |
94 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.00070729 |
95 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.99633690 |
96 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.99529291 |
97 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.99472255 |
98 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.99472255 |
99 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.99472255 |
100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99329568 |
101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98318879 |
102 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97821691 |
103 | FUS_26573619_Chip-Seq_HEK293_Human | 0.97642579 |
104 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96694545 |
105 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96626794 |
106 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96366233 |
107 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96138335 |
108 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.95580044 |
109 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95224500 |
110 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.93908857 |
111 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93779958 |
112 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92913329 |
113 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.92899821 |
114 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.92490608 |
115 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92135992 |
116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91944156 |
117 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.91646579 |
118 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.91132242 |
119 | P300_19829295_ChIP-Seq_ESCs_Human | 0.89336868 |
120 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 0.88915256 |
121 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.88172230 |
122 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.88159616 |
123 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.87792036 |
124 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.86819172 |
125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85753560 |
126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.85663400 |
127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84650431 |
128 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.83852019 |
129 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83808618 |
130 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.83253741 |
131 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.81341562 |
132 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.81301595 |
133 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.81099767 |
134 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.80728858 |
135 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.80675387 |
136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80171280 |
137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77845691 |
138 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.77680386 |
139 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.76210962 |
140 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.75847714 |
141 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.75427529 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.36632376 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.97930025 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.18402289 |
4 | MP0003806_abnormal_nucleotide_metabolis | 5.17580152 |
5 | MP0005365_abnormal_bile_salt | 4.90943065 |
6 | MP0003941_abnormal_skin_development | 4.74682244 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.38093421 |
8 | MP0005332_abnormal_amino_acid | 3.67738961 |
9 | MP0009840_abnormal_foam_cell | 3.44224645 |
10 | MP0004019_abnormal_vitamin_homeostasis | 3.24093755 |
11 | MP0003195_calcinosis | 2.87294643 |
12 | MP0003252_abnormal_bile_duct | 2.84458795 |
13 | MP0010329_abnormal_lipoprotein_level | 2.76396788 |
14 | MP0008058_abnormal_DNA_repair | 2.66167766 |
15 | MP0008007_abnormal_cellular_replicative | 2.14100044 |
16 | MP0005083_abnormal_biliary_tract | 2.05563931 |
17 | MP0004272_abnormal_basement_membrane | 2.01108219 |
18 | MP0008877_abnormal_DNA_methylation | 1.98044655 |
19 | MP0003122_maternal_imprinting | 1.89478786 |
20 | MP0005451_abnormal_body_composition | 1.88785851 |
21 | MP0009643_abnormal_urine_homeostasis | 1.85245108 |
22 | MP0004043_abnormal_pH_regulation | 1.84938904 |
23 | MP0005319_abnormal_enzyme/_coenzyme | 1.83955889 |
24 | MP0001666_abnormal_nutrient_absorption | 1.83170984 |
25 | MP0000579_abnormal_nail_morphology | 1.82529969 |
26 | MP0003718_maternal_effect | 1.79794786 |
27 | MP0000609_abnormal_liver_physiology | 1.73775982 |
28 | MP0008057_abnormal_DNA_replication | 1.69452522 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.69255790 |
30 | MP0003937_abnormal_limbs/digits/tail_de | 1.67818065 |
31 | MP0001764_abnormal_homeostasis | 1.64861519 |
32 | MP0002118_abnormal_lipid_homeostasis | 1.64247424 |
33 | MP0003186_abnormal_redox_activity | 1.61628474 |
34 | MP0002138_abnormal_hepatobiliary_system | 1.51937577 |
35 | MP0003693_abnormal_embryo_hatching | 1.50339463 |
36 | MP0002697_abnormal_eye_size | 1.49883309 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.48134048 |
38 | MP0002938_white_spotting | 1.42386557 |
39 | MP0001756_abnormal_urination | 1.41138343 |
40 | MP0003121_genomic_imprinting | 1.38464708 |
41 | MP0004957_abnormal_blastocyst_morpholog | 1.37017675 |
42 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36780546 |
43 | MP0003111_abnormal_nucleus_morphology | 1.34581693 |
44 | MP0003646_muscle_fatigue | 1.31345318 |
45 | MP0010030_abnormal_orbit_morphology | 1.30236573 |
46 | MP0003119_abnormal_digestive_system | 1.30152349 |
47 | MP0001188_hyperpigmentation | 1.29253110 |
48 | MP0002085_abnormal_embryonic_tissue | 1.28830064 |
49 | MP0001177_atelectasis | 1.28117350 |
50 | MP0001286_abnormal_eye_development | 1.25325957 |
51 | MP0005636_abnormal_mineral_homeostasis | 1.24193356 |
52 | MP0006036_abnormal_mitochondrial_physio | 1.23531839 |
53 | MP0000350_abnormal_cell_proliferation | 1.23197031 |
54 | MP0002090_abnormal_vision | 1.19974476 |
55 | MP0009703_decreased_birth_body | 1.18885458 |
56 | MP0002233_abnormal_nose_morphology | 1.16736229 |
57 | MP0006035_abnormal_mitochondrial_morpho | 1.15739926 |
58 | MP0006292_abnormal_olfactory_placode | 1.12619672 |
59 | MP0001529_abnormal_vocalization | 1.12555961 |
60 | MP0000537_abnormal_urethra_morphology | 1.08197532 |
61 | MP0000598_abnormal_liver_morphology | 1.07970082 |
62 | MP0003136_yellow_coat_color | 1.07539743 |
63 | MP0005395_other_phenotype | 1.06418555 |
64 | MP0003868_abnormal_feces_composition | 1.04699156 |
65 | MP0009697_abnormal_copulation | 1.04694179 |
66 | MP0005670_abnormal_white_adipose | 1.03101215 |
67 | MP0004133_heterotaxia | 1.02154288 |
68 | MP0003315_abnormal_perineum_morphology | 1.00413695 |
69 | MP0002136_abnormal_kidney_physiology | 0.99075258 |
70 | MP0004215_abnormal_myocardial_fiber | 0.99010097 |
71 | MP0000647_abnormal_sebaceous_gland | 0.96570766 |
72 | MP0005266_abnormal_metabolism | 0.95157165 |
73 | MP0001730_embryonic_growth_arrest | 0.94622993 |
74 | MP0001299_abnormal_eye_distance/ | 0.94333380 |
75 | MP0009672_abnormal_birth_weight | 0.93525158 |
76 | MP0003329_amyloid_beta_deposits | 0.91071898 |
77 | MP0000566_synostosis | 0.91046976 |
78 | MP0000762_abnormal_tongue_morphology | 0.90381033 |
79 | MP0010234_abnormal_vibrissa_follicle | 0.89578806 |
80 | MP0002111_abnormal_tail_morphology | 0.89076745 |
81 | MP0001661_extended_life_span | 0.88386711 |
82 | MP0009053_abnormal_anal_canal | 0.88374722 |
83 | MP0003950_abnormal_plasma_membrane | 0.88238456 |
84 | MP0001984_abnormal_olfaction | 0.86456276 |
85 | MP0003878_abnormal_ear_physiology | 0.84974563 |
86 | MP0005377_hearing/vestibular/ear_phenot | 0.84974563 |
87 | MP0001915_intracranial_hemorrhage | 0.82921737 |
88 | MP0001765_abnormal_ion_homeostasis | 0.82824573 |
89 | MP0008260_abnormal_autophagy | 0.80350734 |
90 | MP0003011_delayed_dark_adaptation | 0.78857330 |
91 | MP0005666_abnormal_adipose_tissue | 0.78817389 |
92 | MP0010307_abnormal_tumor_latency | 0.78090167 |
93 | MP0000604_amyloidosis | 0.77943941 |
94 | MP0004264_abnormal_extraembryonic_tissu | 0.77681988 |
95 | MP0010094_abnormal_chromosome_stability | 0.77577906 |
96 | MP0003755_abnormal_palate_morphology | 0.77328382 |
97 | MP0002269_muscular_atrophy | 0.77124189 |
98 | MP0005376_homeostasis/metabolism_phenot | 0.75912330 |
99 | MP0006072_abnormal_retinal_apoptosis | 0.71894623 |
100 | MP0002092_abnormal_eye_morphology | 0.71443590 |
101 | MP0003077_abnormal_cell_cycle | 0.70964495 |
102 | MP0001672_abnormal_embryogenesis/_devel | 0.70348450 |
103 | MP0005380_embryogenesis_phenotype | 0.70348450 |
104 | MP0003221_abnormal_cardiomyocyte_apopto | 0.69346984 |
105 | MP0005501_abnormal_skin_physiology | 0.68987356 |
106 | MP0003786_premature_aging | 0.68965860 |
107 | MP0002751_abnormal_autonomic_nervous | 0.68148601 |
108 | MP0002102_abnormal_ear_morphology | 0.67162159 |
109 | MP0002796_impaired_skin_barrier | 0.66592802 |
110 | MP0005647_abnormal_sex_gland | 0.66300345 |
111 | MP0009642_abnormal_blood_homeostasis | 0.65244087 |
112 | MP0004885_abnormal_endolymph | 0.63930843 |
113 | MP0003861_abnormal_nervous_system | 0.63316570 |
114 | MP0002088_abnormal_embryonic_growth/wei | 0.63068649 |
115 | MP0005408_hypopigmentation | 0.62561754 |
116 | MP0003566_abnormal_cell_adhesion | 0.62411239 |
117 | MP0003984_embryonic_growth_retardation | 0.61898104 |
118 | MP0005394_taste/olfaction_phenotype | 0.61239525 |
119 | MP0005499_abnormal_olfactory_system | 0.61239525 |
120 | MP0008789_abnormal_olfactory_epithelium | 0.60750440 |
121 | MP0002736_abnormal_nociception_after | 0.60208529 |
122 | MP0001929_abnormal_gametogenesis | 0.59972978 |
123 | MP0005058_abnormal_lysosome_morphology | 0.59911551 |
124 | MP0002086_abnormal_extraembryonic_tissu | 0.57927086 |
125 | MP0000358_abnormal_cell_content/ | 0.56224538 |
126 | MP0004084_abnormal_cardiac_muscle | 0.55857129 |
127 | MP0003567_abnormal_fetal_cardiomyocyte | 0.54817812 |
128 | MP0009763_increased_sensitivity_to | 0.53442754 |
129 | MP0002254_reproductive_system_inflammat | 0.53116412 |
130 | MP0000747_muscle_weakness | 0.52654207 |
131 | MP0001697_abnormal_embryo_size | 0.52605218 |
132 | MP0005330_cardiomyopathy | 0.52492518 |
133 | MP0003656_abnormal_erythrocyte_physiolo | 0.51758652 |
134 | MP0002080_prenatal_lethality | 0.50845316 |
135 | MP0002971_abnormal_brown_adipose | 0.50254726 |
136 | MP0002078_abnormal_glucose_homeostasis | 0.49800561 |
137 | MP0003123_paternal_imprinting | 0.46902896 |
138 | MP0010352_gastrointestinal_tract_polyps | 0.46681944 |
139 | MP0003699_abnormal_female_reproductive | 0.46282802 |
140 | MP0005084_abnormal_gallbladder_morpholo | 0.46276402 |
141 | MP0002168_other_aberrant_phenotype | 0.44323049 |
142 | MP0002653_abnormal_ependyma_morphology | 0.43953062 |
143 | MP0009765_abnormal_xenobiotic_induced | 0.43374474 |
144 | MP0002084_abnormal_developmental_patter | 0.42640323 |
145 | MP0003890_abnormal_embryonic-extraembry | 0.42403453 |
146 | MP0005535_abnormal_body_temperature | 0.41641491 |
147 | MP0005187_abnormal_penis_morphology | 0.41068707 |
148 | MP0008932_abnormal_embryonic_tissue | 0.39289147 |
149 | MP0004130_abnormal_muscle_cell | 0.38446802 |
150 | MP0001293_anophthalmia | 0.37613046 |
151 | MP0003638_abnormal_response/metabolism_ | 0.37343437 |
152 | MP0004197_abnormal_fetal_growth/weight/ | 0.37307629 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperglycinuria (HP:0003108) | 6.02566167 |
2 | Hyperglycinemia (HP:0002154) | 5.72426611 |
3 | Abnormality of glycine metabolism (HP:0010895) | 5.52782647 |
4 | Abnormality of serine family amino acid metabolism (HP:0010894) | 5.52782647 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.46148893 |
6 | Intrahepatic cholestasis (HP:0001406) | 5.42916272 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.30889820 |
8 | Gout (HP:0001997) | 5.24874527 |
9 | Xanthomatosis (HP:0000991) | 5.08329185 |
10 | Deep venous thrombosis (HP:0002625) | 4.86810836 |
11 | Hyperammonemia (HP:0001987) | 4.78645545 |
12 | Hypobetalipoproteinemia (HP:0003563) | 4.74453095 |
13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.67177136 |
14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26135617 |
15 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22336645 |
16 | Ketosis (HP:0001946) | 4.15956870 |
17 | Hyperlipoproteinemia (HP:0010980) | 4.10869518 |
18 | Abnormality of serum amino acid levels (HP:0003112) | 3.90910076 |
19 | Hypolipoproteinemia (HP:0010981) | 3.87109303 |
20 | Abnormality of the labia minora (HP:0012880) | 3.84349187 |
21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78398482 |
22 | Proximal tubulopathy (HP:0000114) | 3.72690774 |
23 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.64714196 |
24 | Prolonged partial thromboplastin time (HP:0003645) | 3.64080377 |
25 | Abnormality of nucleobase metabolism (HP:0010932) | 3.63346590 |
26 | Hyperuricemia (HP:0002149) | 3.60443665 |
27 | Increased purine levels (HP:0004368) | 3.60443665 |
28 | Delayed CNS myelination (HP:0002188) | 3.59574983 |
29 | Abnormality of methionine metabolism (HP:0010901) | 3.59316463 |
30 | Hypoalphalipoproteinemia (HP:0003233) | 3.56595489 |
31 | Abnormality of purine metabolism (HP:0004352) | 3.55820644 |
32 | Hypoglycemic coma (HP:0001325) | 3.41724953 |
33 | Colon cancer (HP:0003003) | 3.39627297 |
34 | Ketoacidosis (HP:0001993) | 3.35574531 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.30820594 |
36 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.21961578 |
37 | Dicarboxylic aciduria (HP:0003215) | 3.21961578 |
38 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.16344015 |
39 | Lethargy (HP:0001254) | 3.11598497 |
40 | Spastic diplegia (HP:0001264) | 3.04792371 |
41 | Chromsome breakage (HP:0040012) | 3.03812145 |
42 | Generalized aminoaciduria (HP:0002909) | 3.00026763 |
43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.91281353 |
44 | Ependymoma (HP:0002888) | 2.85356370 |
45 | Metabolic acidosis (HP:0001942) | 2.82698042 |
46 | Complement deficiency (HP:0004431) | 2.81366598 |
47 | Epidermoid cyst (HP:0200040) | 2.81104012 |
48 | Fat malabsorption (HP:0002630) | 2.79727956 |
49 | Irritability (HP:0000737) | 2.78201752 |
50 | Alkalosis (HP:0001948) | 2.76680179 |
51 | Embryonal renal neoplasm (HP:0011794) | 2.75850699 |
52 | Meckel diverticulum (HP:0002245) | 2.72424927 |
53 | Malnutrition (HP:0004395) | 2.71606836 |
54 | Abnormal lung lobation (HP:0002101) | 2.66625045 |
55 | Hypoglycemic seizures (HP:0002173) | 2.65798695 |
56 | Rhabdomyosarcoma (HP:0002859) | 2.64914654 |
57 | Birth length less than 3rd percentile (HP:0003561) | 2.59337059 |
58 | Glycosuria (HP:0003076) | 2.58138642 |
59 | Abnormality of urine glucose concentration (HP:0011016) | 2.58138642 |
60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.56603599 |
61 | Cholecystitis (HP:0001082) | 2.53536166 |
62 | Cortical dysplasia (HP:0002539) | 2.53292667 |
63 | Abnormality of the ileum (HP:0001549) | 2.52656405 |
64 | Increased circulating renin level (HP:0000848) | 2.51646880 |
65 | Hepatocellular carcinoma (HP:0001402) | 2.51179906 |
66 | Vascular calcification (HP:0004934) | 2.50648278 |
67 | Megaloblastic anemia (HP:0001889) | 2.48756484 |
68 | Abnormality of the common coagulation pathway (HP:0010990) | 2.45312426 |
69 | Joint hemorrhage (HP:0005261) | 2.44473209 |
70 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.44302279 |
71 | Hypokalemic alkalosis (HP:0001949) | 2.39268757 |
72 | Hepatoblastoma (HP:0002884) | 2.39090682 |
73 | Exercise-induced muscle cramps (HP:0003710) | 2.35757468 |
74 | Abnormal cartilage morphology (HP:0002763) | 2.34698035 |
75 | Confusion (HP:0001289) | 2.34465664 |
76 | Abnormality of chromosome stability (HP:0003220) | 2.33840680 |
77 | Nausea (HP:0002018) | 2.33735544 |
78 | Abnormality of proline metabolism (HP:0010907) | 2.32691791 |
79 | Hydroxyprolinuria (HP:0003080) | 2.32691791 |
80 | Vomiting (HP:0002013) | 2.32128839 |
81 | Neonatal onset (HP:0003623) | 2.31435190 |
82 | Neoplasm of the adrenal gland (HP:0100631) | 2.30631167 |
83 | Hyperbilirubinemia (HP:0002904) | 2.27478365 |
84 | Medulloblastoma (HP:0002885) | 2.24711384 |
85 | Rickets (HP:0002748) | 2.21958677 |
86 | Hyperactive renin-angiotensin system (HP:0000841) | 2.21223156 |
87 | Hypercholesterolemia (HP:0003124) | 2.20336240 |
88 | Cerebral edema (HP:0002181) | 2.19669548 |
89 | Bifid tongue (HP:0010297) | 2.19260227 |
90 | Abnormality of the preputium (HP:0100587) | 2.17650861 |
91 | Abnormality of the intrinsic pathway (HP:0010989) | 2.16803998 |
92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.16495630 |
93 | Absent radius (HP:0003974) | 2.15515893 |
94 | Cardiovascular calcification (HP:0011915) | 2.15496501 |
95 | Choanal stenosis (HP:0000452) | 2.14339288 |
96 | Abnormal urine output (HP:0012590) | 2.12255243 |
97 | Spontaneous abortion (HP:0005268) | 2.10757759 |
98 | Metabolic alkalosis (HP:0200114) | 2.09444783 |
99 | Polyuria (HP:0000103) | 2.08716373 |
100 | Glioma (HP:0009733) | 2.08528568 |
101 | Multiple enchondromatosis (HP:0005701) | 2.07519953 |
102 | Stenosis of the external auditory canal (HP:0000402) | 2.06676599 |
103 | Status epilepticus (HP:0002133) | 2.04363693 |
104 | Absent forearm bone (HP:0003953) | 2.02010223 |
105 | Aplasia involving forearm bones (HP:0009822) | 2.02010223 |
106 | Metaphyseal cupping (HP:0003021) | 2.01834599 |
107 | Pterygium (HP:0001059) | 2.01346460 |
108 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.01259609 |
109 | Reduced antithrombin III activity (HP:0001976) | 2.01215203 |
110 | Conjugated hyperbilirubinemia (HP:0002908) | 1.99438133 |
111 | Agnosia (HP:0010524) | 1.98537531 |
112 | Astrocytoma (HP:0009592) | 1.97809483 |
113 | Abnormality of the astrocytes (HP:0100707) | 1.97809483 |
114 | Steatorrhea (HP:0002570) | 1.97655293 |
115 | Postnatal microcephaly (HP:0005484) | 1.95923777 |
116 | Global brain atrophy (HP:0002283) | 1.95896372 |
117 | Hyperglycemia (HP:0003074) | 1.95792473 |
118 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95650467 |
119 | Nephrolithiasis (HP:0000787) | 1.95069952 |
120 | Methylmalonic aciduria (HP:0012120) | 1.94445291 |
121 | Abnormality of complement system (HP:0005339) | 1.92639606 |
122 | Enlarged kidneys (HP:0000105) | 1.91385559 |
123 | Supernumerary spleens (HP:0009799) | 1.89920721 |
124 | Increased serum pyruvate (HP:0003542) | 1.89723153 |
125 | Abnormality of glycolysis (HP:0004366) | 1.89723153 |
126 | Abnormality of alanine metabolism (HP:0010916) | 1.89194268 |
127 | Hyperalaninemia (HP:0003348) | 1.89194268 |
128 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.89194268 |
129 | Increased nuchal translucency (HP:0010880) | 1.88812842 |
130 | Abnormality of renal excretion (HP:0011036) | 1.88794016 |
131 | Symptomatic seizures (HP:0011145) | 1.88319056 |
132 | Skin nodule (HP:0200036) | 1.88080110 |
133 | Late onset (HP:0003584) | 1.87727748 |
134 | Bilateral microphthalmos (HP:0007633) | 1.86931027 |
135 | Absent eyebrow (HP:0002223) | 1.86572115 |
136 | Sensorimotor neuropathy (HP:0007141) | 1.86143087 |
137 | Right ventricular cardiomyopathy (HP:0011663) | 1.85922635 |
138 | Back pain (HP:0003418) | 1.85455477 |
139 | Abnormality of chloride homeostasis (HP:0011422) | 1.85204956 |
140 | Tetraplegia (HP:0002445) | 1.84840223 |
141 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.84517869 |
142 | Myelomeningocele (HP:0002475) | 1.83821404 |
143 | Abnormality of vitamin metabolism (HP:0100508) | 1.79733648 |
144 | Esophageal varix (HP:0002040) | 1.79273973 |
145 | Abnormality of the duodenum (HP:0002246) | 1.79078579 |
146 | Duodenal stenosis (HP:0100867) | 1.78573510 |
147 | Small intestinal stenosis (HP:0012848) | 1.78573510 |
148 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.77999611 |
149 | Hyperphosphaturia (HP:0003109) | 1.77534810 |
150 | Hypomagnesemia (HP:0002917) | 1.77168717 |
151 | Spastic paraparesis (HP:0002313) | 1.76183776 |
152 | Abnormal gallbladder physiology (HP:0012438) | 1.74026673 |
153 | Horseshoe kidney (HP:0000085) | 1.74002959 |
154 | Biliary tract neoplasm (HP:0100574) | 1.72401983 |
155 | Gonadotropin excess (HP:0000837) | 1.72135363 |
156 | Embryonal neoplasm (HP:0002898) | 1.71297269 |
157 | Hypoplastic female external genitalia (HP:0012815) | 1.69570386 |
158 | Absent eyelashes (HP:0000561) | 1.69435455 |
159 | Septo-optic dysplasia (HP:0100842) | 1.69349967 |
160 | Acute encephalopathy (HP:0006846) | 1.68585558 |
161 | Methylmalonic acidemia (HP:0002912) | 1.67210006 |
162 | Hypoplastic pelvis (HP:0008839) | 1.65020420 |
163 | Facial cleft (HP:0002006) | 1.64553836 |
164 | Ovarian neoplasm (HP:0100615) | 1.64407664 |
165 | Uterine neoplasm (HP:0010784) | 1.63267594 |
166 | Anal stenosis (HP:0002025) | 1.62966108 |
167 | Neoplasm of the colon (HP:0100273) | 1.62519131 |
168 | Breast aplasia (HP:0100783) | 1.61352250 |
169 | Abnormality of the parathyroid morphology (HP:0011766) | 1.60917307 |
170 | Type I transferrin isoform profile (HP:0003642) | 1.60240923 |
171 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.56351780 |
172 | Labial hypoplasia (HP:0000066) | 1.54677139 |
173 | Gastrointestinal carcinoma (HP:0002672) | 1.54553834 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NEK1 | 4.85888347 |
2 | BCKDK | 4.76044911 |
3 | WEE1 | 3.78459957 |
4 | PBK | 3.63351234 |
5 | EPHA2 | 3.28413725 |
6 | WNK3 | 3.15829433 |
7 | STK38L | 2.94229292 |
8 | TNIK | 2.93869092 |
9 | MKNK2 | 2.93180541 |
10 | TRIM28 | 2.62620078 |
11 | PDK4 | 2.55283751 |
12 | PDK3 | 2.55283751 |
13 | MKNK1 | 2.54774818 |
14 | BUB1 | 2.53830553 |
15 | TTK | 2.31587202 |
16 | VRK2 | 2.06589513 |
17 | WNK4 | 2.06325387 |
18 | PNCK | 2.03069490 |
19 | MST4 | 1.96814717 |
20 | AKT3 | 1.93983937 |
21 | EIF2AK1 | 1.92966182 |
22 | PKN2 | 1.84309636 |
23 | LATS2 | 1.77728579 |
24 | OXSR1 | 1.75419373 |
25 | FGFR4 | 1.73081193 |
26 | TSSK6 | 1.70954413 |
27 | PDK2 | 1.70887550 |
28 | TAF1 | 1.69315339 |
29 | NEK2 | 1.67277687 |
30 | STK38 | 1.51450052 |
31 | LATS1 | 1.45406167 |
32 | PINK1 | 1.41388485 |
33 | TRIB3 | 1.39159378 |
34 | BCR | 1.37977112 |
35 | NUAK1 | 1.35701147 |
36 | BMPR1B | 1.31632809 |
37 | CDK4 | 1.25349816 |
38 | ERBB4 | 1.19633214 |
39 | PLK1 | 1.17487420 |
40 | SIK1 | 1.16209945 |
41 | BRSK2 | 1.09632060 |
42 | TAOK2 | 1.08546282 |
43 | MST1R | 1.03374212 |
44 | ABL2 | 1.02850625 |
45 | MAP3K8 | 1.00789888 |
46 | VRK1 | 1.00124915 |
47 | PLK3 | 0.97365963 |
48 | MAP2K4 | 0.96179238 |
49 | CDC7 | 0.96124716 |
50 | EPHA4 | 0.94966120 |
51 | MAP3K9 | 0.94350167 |
52 | STK39 | 0.92955691 |
53 | FLT3 | 0.92930258 |
54 | ACVR1B | 0.92467311 |
55 | STK24 | 0.92029798 |
56 | ARAF | 0.90987543 |
57 | EIF2AK2 | 0.90412264 |
58 | MAPK11 | 0.88062349 |
59 | PLK4 | 0.85083394 |
60 | MAP3K3 | 0.85079952 |
61 | AURKA | 0.84494791 |
62 | BRAF | 0.84453260 |
63 | ALK | 0.84034009 |
64 | NME2 | 0.84001607 |
65 | ATR | 0.80767261 |
66 | MET | 0.80481069 |
67 | STK16 | 0.80261540 |
68 | PLK2 | 0.76472688 |
69 | CASK | 0.75894477 |
70 | CSNK1G1 | 0.75493052 |
71 | KSR2 | 0.73181046 |
72 | STK3 | 0.72997071 |
73 | PRKAA1 | 0.72353404 |
74 | KSR1 | 0.71548174 |
75 | ATM | 0.69988433 |
76 | MTOR | 0.69928000 |
77 | MAP3K5 | 0.69001368 |
78 | AURKB | 0.68027221 |
79 | BRSK1 | 0.67494476 |
80 | PRKCI | 0.66603374 |
81 | CSNK1E | 0.66286935 |
82 | CHEK2 | 0.66017729 |
83 | EIF2AK3 | 0.64836626 |
84 | SGK3 | 0.62976455 |
85 | RPS6KB2 | 0.62523823 |
86 | TGFBR1 | 0.61321754 |
87 | MAP3K11 | 0.60965409 |
88 | CDK12 | 0.59936361 |
89 | STK4 | 0.59523879 |
90 | PAK4 | 0.57064407 |
91 | FGFR2 | 0.56949089 |
92 | SGK494 | 0.56298767 |
93 | SGK223 | 0.56298767 |
94 | NME1 | 0.53475592 |
95 | BRD4 | 0.53236403 |
96 | SGK2 | 0.52098650 |
97 | PRKCG | 0.51143141 |
98 | SRPK1 | 0.51036566 |
99 | DYRK2 | 0.49714578 |
100 | CSNK1G2 | 0.48940438 |
101 | CDK6 | 0.48825219 |
102 | ERBB3 | 0.48707206 |
103 | CSNK1A1L | 0.48596317 |
104 | AKT2 | 0.48316050 |
105 | GRK6 | 0.47816204 |
106 | CHEK1 | 0.47637935 |
107 | RIPK1 | 0.45980905 |
108 | CDK2 | 0.45279120 |
109 | RPS6KA4 | 0.45013378 |
110 | ERN1 | 0.44984750 |
111 | DYRK3 | 0.44652068 |
112 | MAP2K3 | 0.44260286 |
113 | CSNK2A1 | 0.44080333 |
114 | PASK | 0.43483822 |
115 | FGFR1 | 0.42893405 |
116 | MELK | 0.42436877 |
117 | PRKDC | 0.42066879 |
118 | FER | 0.41348994 |
119 | NLK | 0.41322363 |
120 | CDK1 | 0.41275458 |
121 | CSNK1G3 | 0.41251447 |
122 | DMPK | 0.41095574 |
123 | CDK7 | 0.39920113 |
124 | GRK1 | 0.37505328 |
125 | YES1 | 0.36746533 |
126 | MINK1 | 0.36527275 |
127 | NEK9 | 0.36501821 |
128 | TESK2 | 0.35692520 |
129 | PRKAA2 | 0.34832912 |
130 | ERBB2 | 0.34670181 |
131 | GSK3A | 0.34330278 |
132 | DAPK1 | 0.34014889 |
133 | PRKACG | 0.33405452 |
134 | CSNK2A2 | 0.33284597 |
135 | CDK19 | 0.33066724 |
136 | RAF1 | 0.32376067 |
137 | PRKCZ | 0.31783253 |
138 | PAK6 | 0.31502100 |
139 | SMG1 | 0.31478569 |
140 | PAK2 | 0.31380975 |
141 | PTK2 | 0.30755834 |
142 | ZAK | 0.30068031 |
143 | CDK18 | 0.30066210 |
144 | SCYL2 | 0.29759481 |
145 | PDPK1 | 0.28509588 |
146 | MAP3K7 | 0.28420592 |
147 | PRKCE | 0.27979366 |
148 | CDK9 | 0.27053655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.38056114 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.33139785 |
3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.24267190 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.22809195 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.15443716 |
6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.86724582 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.80088128 |
8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.74410014 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54572330 |
10 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.46668367 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36068432 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.28642182 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24447611 |
14 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21750571 |
15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.12158656 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.07050361 |
17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.99226288 |
18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.95274815 |
19 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.94816966 |
20 | Peroxisome_Homo sapiens_hsa04146 | 1.91307266 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.91256845 |
22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.89983218 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79527075 |
24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.78066029 |
25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72679132 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72641463 |
27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72492913 |
28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68680183 |
29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67109680 |
30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.66111061 |
31 | Protein export_Homo sapiens_hsa03060 | 1.57701370 |
32 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.57671303 |
33 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57655340 |
34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.52692107 |
35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.48357029 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.48075521 |
37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46034452 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.44283968 |
39 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.41622662 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.40390085 |
41 | Homologous recombination_Homo sapiens_hsa03440 | 1.39006732 |
42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36795040 |
43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35536911 |
44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.31814530 |
45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31060153 |
46 | Base excision repair_Homo sapiens_hsa03410 | 1.30936039 |
47 | Histidine metabolism_Homo sapiens_hsa00340 | 1.29714462 |
48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28269802 |
49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25467065 |
50 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24432837 |
51 | RNA degradation_Homo sapiens_hsa03018 | 1.21448376 |
52 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20392771 |
53 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20277966 |
54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.16344988 |
55 | Spliceosome_Homo sapiens_hsa03040 | 1.14498624 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11029857 |
57 | Basal transcription factors_Homo sapiens_hsa03022 | 1.08731808 |
58 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.06721038 |
59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99557894 |
60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.97832675 |
61 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93190704 |
62 | Lysine degradation_Homo sapiens_hsa00310 | 0.91126148 |
63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.89881213 |
64 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.84659228 |
65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80864901 |
66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.78211016 |
67 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77019451 |
68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76850085 |
69 | Proteasome_Homo sapiens_hsa03050 | 0.73341652 |
70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72835155 |
71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.63198798 |
72 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62440940 |
73 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58108483 |
74 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.57649079 |
75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57058890 |
76 | ABC transporters_Homo sapiens_hsa02010 | 0.56516151 |
77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55813049 |
78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53494075 |
79 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53129060 |
80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.52535497 |
81 | Adherens junction_Homo sapiens_hsa04520 | 0.51985482 |
82 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51130008 |
83 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50886967 |
84 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47794031 |
85 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.47652481 |
86 | RNA transport_Homo sapiens_hsa03013 | 0.47439614 |
87 | Tight junction_Homo sapiens_hsa04530 | 0.45685296 |
88 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44385549 |
89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42872696 |
90 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.42556375 |
91 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41870447 |
92 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41554627 |
93 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.40924171 |
94 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.39699003 |
95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39361778 |
96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.38637884 |
97 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37968929 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37116837 |
99 | Ribosome_Homo sapiens_hsa03010 | 0.35654797 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33275298 |
101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.30748210 |
102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.28571940 |
103 | RNA polymerase_Homo sapiens_hsa03020 | 0.24652881 |
104 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23335942 |
105 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.20600449 |
106 | Mismatch repair_Homo sapiens_hsa03430 | 0.20283617 |
107 | DNA replication_Homo sapiens_hsa03030 | 0.18400850 |
108 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.13246059 |
109 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12688421 |
110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10356574 |
111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.09028039 |
112 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.08842999 |
113 | Insulin resistance_Homo sapiens_hsa04931 | 0.06823959 |
114 | Mineral absorption_Homo sapiens_hsa04978 | 0.05549584 |
115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.04209385 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.01503964 |
117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.01450055 |
118 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.01097513 |
119 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0715803 |
120 | mTOR signaling pathway_Homo sapiens_hsa04150 | -0.0632394 |
121 | * Purine metabolism_Homo sapiens_hsa00230 | -0.0574594 |
122 | Cell cycle_Homo sapiens_hsa04110 | -0.0512265 |
123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.0380527 |
124 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.0289588 |
125 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0257863 |